Accumulation of amyloid-beta (Aβ) and tau proteins, partly because of impaired protein clearance mechanisms, is a pathological hallmark of AD (Da Mesquita et al., 2018; Jack et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.